Sunil Kumar

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 12, 2024
In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer.

Sunil Kumar, Iqra Ali, Faheem Abbas

|Aug 30, 2023
In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer.

Sunil Kumar, Iqra Ali, Faheem Abbas

|Aug 14, 2023
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.

Sunil Kumar, Iqra Ali, Faheem Abbas

|Apr 28, 2023
Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer.

Sunil Kumar, Sounok Sengupta, Iqra Ali

|Apr 07, 2023
Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy.

Sunil Kumar, Monu Kumar Shukla, Abhishek Kumar Sharma

Pageof 1

Frequent Collaborators

5 joint publications

Deepak Kumar

4 joint publications

Iqra Ali

3 joint publications

Faheem Abbas

1 joint publications

Sounok Sengupta